AU2002336433A1 - Tricyclic compounds useful for modulating lxr - Google Patents
Tricyclic compounds useful for modulating lxrInfo
- Publication number
- AU2002336433A1 AU2002336433A1 AU2002336433A AU2002336433A AU2002336433A1 AU 2002336433 A1 AU2002336433 A1 AU 2002336433A1 AU 2002336433 A AU2002336433 A AU 2002336433A AU 2002336433 A AU2002336433 A AU 2002336433A AU 2002336433 A1 AU2002336433 A1 AU 2002336433A1
- Authority
- AU
- Australia
- Prior art keywords
- compounds useful
- tricyclic compounds
- modulating lxr
- lxr
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32764401P | 2001-10-08 | 2001-10-08 | |
| US60/327,644 | 2001-10-08 | ||
| PCT/US2002/028147 WO2003031408A2 (en) | 2001-10-08 | 2002-09-30 | Tricyclic compounds useful for modulating lxr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002336433A1 true AU2002336433A1 (en) | 2003-04-22 |
Family
ID=23277404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002336433A Abandoned AU2002336433A1 (en) | 2001-10-08 | 2002-09-30 | Tricyclic compounds useful for modulating lxr |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002336433A1 (en) |
| WO (1) | WO2003031408A2 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004072046A2 (en) * | 2003-02-12 | 2004-08-26 | Carex S.A. | Quinoline derivatives and their use for modulation of lxr activity |
| TW200529845A (en) * | 2003-12-12 | 2005-09-16 | Wyeth Corp | Quinolines useful in treating cardiovascular disease |
| EP1806332A4 (en) | 2004-10-27 | 2010-03-31 | Daiichi Sankyo Co Ltd | Benzene compound having 2 or more substituents |
| WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| CA2741672A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| WO2011106273A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| CN103517908A (en) | 2010-09-07 | 2014-01-15 | Seoul大学校产学协力财团 | Sesterterpene compounds and use thereof |
| EA025380B1 (en) | 2011-02-25 | 2016-12-30 | Мерк Шарп Энд Домэ Корп. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| KR20150036245A (en) | 2012-08-02 | 2015-04-07 | 머크 샤프 앤드 돔 코포레이션 | Antidiabetic tricyclic compounds |
| RU2015140066A (en) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | ANTI-DIABETIC BICYCLIC COMPOUNDS |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2015106164A1 (en) | 2014-01-10 | 2015-07-16 | Rgenix, Inc. | Lxr agonists and uses thereof |
| CN109069461A (en) | 2016-01-11 | 2018-12-21 | 洛克菲勒大学 | The treatment method of illness relevant to marrow source property inhibition cell |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| EP3713575A4 (en) | 2017-11-21 | 2021-08-25 | Rgenix, Inc. | Polymorphs and uses thereof |
| CN111303017B (en) * | 2019-08-28 | 2022-11-11 | 上海中医药大学 | Compound containing 9, 10-dihydrophenanthrene skeleton and preparation method and application thereof |
| CA3161274A1 (en) | 2019-12-13 | 2021-06-17 | Stephen Wald | Metal salts and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| WO1999066915A2 (en) * | 1998-06-23 | 1999-12-29 | Southern Illinois University At Carbondale | Therapeutic applications of estrogenic carboxylic acids |
| CA2392568A1 (en) * | 1999-12-13 | 2001-06-14 | Merck & Co., Inc. | Method for the prevention and/or treatment of atherosclerosis |
-
2002
- 2002-09-30 WO PCT/US2002/028147 patent/WO2003031408A2/en not_active Application Discontinuation
- 2002-09-30 AU AU2002336433A patent/AU2002336433A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003031408A2 (en) | 2003-04-17 |
| WO2003031408A3 (en) | 2003-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002323787A1 (en) | Spiro compounds | |
| AU2002349297A1 (en) | Statin-like compounds | |
| AU2002218266A1 (en) | Novel indanylidene compounds | |
| AUPS137402A0 (en) | Novel tricyclic compounds | |
| AU2001252574A1 (en) | Novel bicyclic compounds | |
| AU2002336433A1 (en) | Tricyclic compounds useful for modulating lxr | |
| AU2000235960A1 (en) | Lxr modulators | |
| AU2001292518A1 (en) | Novel compounds | |
| AU2002359165A1 (en) | Novel compounds | |
| AU2001239765A1 (en) | Novel compounds | |
| AU2001246998A1 (en) | Novel compounds | |
| AU2001253362A1 (en) | Novel compounds | |
| AUPR878201A0 (en) | New compounds | |
| AU2001288110A1 (en) | Spiro compounds | |
| AU2002231077A1 (en) | Novel compounds | |
| AU2001256964A1 (en) | Novel compounds | |
| AU2001252575A1 (en) | Novel tricyclic compounds | |
| AU2001230689A1 (en) | Novel compounds | |
| AU2002216060A1 (en) | Novel compounds | |
| AU2002221923A1 (en) | Novel compounds | |
| AU2001276890A1 (en) | Novel compounds | |
| AU2001252573A1 (en) | Novel substituted tricyclic compounds | |
| AUPR920301A0 (en) | Neurologically-active compounds | |
| AU2001258760A1 (en) | Novel thiophenamide compounds | |
| AU2001237533A1 (en) | Novel p-gp-inhibiting compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |